988
Views
5
CrossRef citations to date
0
Altmetric
Articles

Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia

, , , , &
Pages 1792-1798 | Received 02 Jun 2017, Accepted 12 Oct 2017, Published online: 07 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jianrong Wang, Yu He, Chao Yang, Qiurui Luo & Bingchi Wang. (2023) Myeloid cell leukemia-1 as a candidate prognostic biomarker in cancers: a systematic review and meta-analysis. Expert Review of Anticancer Therapy 0:0, pages 1-11.
Read now
Muhammad R. Suleiman, Hanxun Wang, Danxia Huang, Huibin Wang, Johnson Joseph, Tianci Huang, Fengjiao Zhang, Jian Wang & Maosheng Cheng. (2021) Discovery of small molecule inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulation and experimental validation against myeloid cell leukemia-1 (Mcl-1). Journal of Biomolecular Structure and Dynamics 39:7, pages 2512-2525.
Read now
Xinxing Guo & Jing Chen. (2019) The protective effects of saxagliptin against lipopolysaccharide (LPS)-induced inflammation and damage in human dental pulp cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1288-1294.
Read now

Articles from other publishers (2)

Qiuyuan Wen, Yuting Zhan, Hongmei Zheng, Hongjing Zang, Jiadi Luo, Yuting Zhang, Weiyuan Wang, Juan Feng, Junmi Lu, Lingjiao Chen & Songqing Fan. (2019) Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer. Diagnostic Pathology 14:1.
Crossref
Yafang Pan, Yu Zhang, Wenwen Liu, Yan Huang, Xianjuan Shen, Rongrong Jing, Jiang Pu, Xudong Wang, Shaoqing Ju, Hui Cong & Hongmei Chen. (2019) LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death & Disease 10:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.